Synergistic with GLP-1 agonists - the CagriSema combination (cagrilintide + semaglutide) shows 15.6% weight loss
Typically, however, semaglutide GLP-1 is meant for obese patients and the general rule of thumb is that its intended for patients with a body mass index (BMI) of 27kg/m2 or higher and/or another condition related to being overweight
On the other hand, to maintain CNS function, the BBB allows passage of nutrients to the brain and elimination of metabolites and/or other potentially harmful molecules to the blood or cerebrospinal fluid (CSF)
Diarrhoea indicates better weight loss This is one of the most persistent misconceptions
This typically includes thyroid function tests (TSH, free T4), fasting glucose and hemoglobin A1c, lipid panel, and potentially cortisol levels if Cushing's syndrome is suspected
It depends on how warm it gets and for how long